Defective T‐cell control of Epstein–Barr virus infection in multiple sclerosis
MP Pender, PA Csurhes, JM Burrows… - Clinical & …, 2017 - Wiley Online Library
Mounting evidence indicates that infection with Epstein–Barr virus (EBV) has a major role in
the pathogenesis of multiple sclerosis (MS). Defective elimination of EBV‐infected B cells by …
the pathogenesis of multiple sclerosis (MS). Defective elimination of EBV‐infected B cells by …
Proinflammatory GM-CSF–producing B cells in multiple sclerosis and B cell depletion therapy
B cells are not limited to producing protective antibodies; they also perform additional
functions relevant to both health and disease. However, the relative contribution of …
functions relevant to both health and disease. However, the relative contribution of …
Next generation B cell targeting therapies in autoimmune diseases
R Li, J Zhu, S Wang, B Zhang, L Tian, Y Fu - Frontiers in Immunology, 2023 - frontiersin.org
B cells are involved in autoimmune diseases through both antibody-dependent and-
independent mechanisms. Broad depletion of B cells using monoclonal antibodies (mAbs) …
independent mechanisms. Broad depletion of B cells using monoclonal antibodies (mAbs) …
Antibody-independent B cell effector functions in relapsing remitting multiple sclerosis: clues to increased inflammatory and reduced regulatory B cell capacity
SJ Ireland, M Blazek, CT Harp, B Greenberg… - …, 2012 - Taylor & Francis
The pathogenic role for B cells in the context of relapsing remitting multiple sclerosis (MS) is
incompletely defined. Although classically considered a T cell-mediated disease, B cell …
incompletely defined. Although classically considered a T cell-mediated disease, B cell …
Epstein–Barr virus and multiple sclerosis: moving from questions of association to questions of mechanism
OG Thomas, A Rickinson… - Clinical & Translational …, 2023 - Wiley Online Library
Abstract The link between Epstein–Barr virus (EBV) and multiple sclerosis (MS) has puzzled
researchers since it was first discovered over 40 years ago. Until that point, EBV was …
researchers since it was first discovered over 40 years ago. Until that point, EBV was …
B cells in multiple sclerosis and virus-induced neuroinflammation
R Chunder, V Schropp, S Kuerten - Frontiers in neurology, 2020 - frontiersin.org
Neuroinflammation can be defined as an inflammatory response within the central nervous
system (CNS) mediated by a complex crosstalk between CNS-resident and infiltrating …
system (CNS) mediated by a complex crosstalk between CNS-resident and infiltrating …
B‐cell targeted therapies in human autoimmune diseases: an updated perspective
MJ Townsend, JG Monroe, AC Chan - Immunological reviews, 2010 - Wiley Online Library
The advent of therapies that specifically target the B‐lymphocyte lineage in human disease
has rejuvenated interest in the mechanistic biology by which B cells mediate autoimmunity …
has rejuvenated interest in the mechanistic biology by which B cells mediate autoimmunity …
Cooperation of B cells and T cells in the pathogenesis of multiple sclerosis
MS Weber, B Hemmer - Molecular Basis of Multiple Sclerosis: The Immune …, 2010 - Springer
B cells and T cells are two major players in the pathogenesis of multiple sclerosis (MS) and
cooperate at various check points. B cells, besides serving as a source for antibody …
cooperate at various check points. B cells, besides serving as a source for antibody …
Targeting B cells in the treatment of multiple sclerosis: recent advances and remaining challenges
K Lehmann-Horn, HC Kronsbein… - Therapeutic advances …, 2013 - journals.sagepub.com
Recent years have substantially broadened our view on the pathogenesis of multiple
sclerosis (MS). While earlier concepts focused predominantly on T lymphocytes as the key …
sclerosis (MS). While earlier concepts focused predominantly on T lymphocytes as the key …
Lymphocytes in MS and EAE: More Than Just a CD4+ World
M Rangachari, SM Kerfoot, N Arbour… - Frontiers in …, 2017 - frontiersin.org
Multiple sclerosis (MS) is an autoimmune disease of the central nervous system (CNS) that
affects nearly two million people worldwide. Disease onset can occur at a young age …
affects nearly two million people worldwide. Disease onset can occur at a young age …